António Carvalho Ferreira Sanctioned Following ABP-Based Anti-Doping Rule Violation – UCI Decision

The ABP anomalies were observed across samples collected in 2018, 2023, and 2024, and were determined to be consistent with the use of a prohibited substance and/or a prohibited method.

The case was resolved through an acceptance of consequences by the rider, as provided for under the World Anti-Doping Code and the UCI Anti-Doping Rules. The period of ineligibility began on 4 November 2025 and will remain in effect until 3 November 2029.

The ABP is an individual electronic record that monitors specific biological variables over time and allows for the indirect detection of doping. The ITA manages the ABP program on behalf of the UCI, in collaboration with the Athlete Passport Management Unit (APMU) based in Lausanne, Switzerland. The APMU operates in association with the WADA-accredited laboratory in Lausanne and supports the evaluation of data through a panel of independent experts. When this expert panel unanimously concludes that the data reflects doping, the case is referred for results management.

While the ABP program and testing operations are conducted independently by the ITA, the UCI retains authority for results management and the prosecution of ADRVs. The sanction in this case was issued by the UCI.

As the matter is now concluded, no further comments will be made.